Prescott Group Capital Management L.L.C. Acquires New Stake in GoodRx Holdings, Inc. $GDRX

Prescott Group Capital Management L.L.C. acquired a new stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,775,502 shares of the company’s stock, valued at approximately $4,812,000. Prescott Group Capital Management L.L.C. owned approximately 0.52% of GoodRx as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Lazard Asset Management LLC increased its position in GoodRx by 43.6% during the 2nd quarter. Lazard Asset Management LLC now owns 17,142 shares of the company’s stock valued at $85,000 after buying an additional 5,201 shares in the last quarter. Brevan Howard Capital Management LP increased its position in GoodRx by 7.7% during the 3rd quarter. Brevan Howard Capital Management LP now owns 95,483 shares of the company’s stock valued at $404,000 after buying an additional 6,842 shares in the last quarter. Hirtle Callaghan & Co LLC increased its position in GoodRx by 60.3% during the 4th quarter. Hirtle Callaghan & Co LLC now owns 18,261 shares of the company’s stock valued at $49,000 after buying an additional 6,869 shares in the last quarter. Tower Research Capital LLC TRC increased its position in GoodRx by 202.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 11,327 shares of the company’s stock valued at $56,000 after buying an additional 7,580 shares in the last quarter. Finally, Quarry LP bought a new position in GoodRx during the 3rd quarter valued at approximately $33,000. Institutional investors own 63.77% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the company. Wall Street Zen downgraded GoodRx from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Citigroup increased their target price on GoodRx from $3.50 to $4.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. Weiss Ratings upgraded GoodRx from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, May 6th. Leerink Partners reiterated an “outperform” rating and set a $3.00 target price on shares of GoodRx in a research note on Thursday, February 26th. Finally, TD Cowen increased their target price on GoodRx from $3.00 to $4.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $3.81.

GoodRx Stock Performance

Shares of GDRX opened at $2.52 on Thursday. The business’s fifty day simple moving average is $2.29 and its two-hundred day simple moving average is $2.51. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.78. GoodRx Holdings, Inc. has a 12 month low of $1.77 and a 12 month high of $5.81. The company has a market cap of $863.29 million, a price-to-earnings ratio of 42.01, a P/E/G ratio of 1.61 and a beta of 1.54.

GoodRx (NASDAQ:GDRX) last issued its earnings results on Wednesday, May 6th. The company reported $0.07 EPS for the quarter, meeting the consensus estimate of $0.07. The business had revenue of $194.01 million for the quarter, compared to the consensus estimate of $185.40 million. GoodRx had a return on equity of 7.90% and a net margin of 2.61%.The company’s revenue was down 4.4% compared to the same quarter last year. During the same period last year, the business posted $0.09 EPS. Research analysts anticipate that GoodRx Holdings, Inc. will post 0.17 earnings per share for the current fiscal year.

About GoodRx

GoodRx Holdings, Inc (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs.